Catheter Precision, Inc.

Catheter Precision, Inc.

AAMEX:VTAK
0.15
USD
+0.00
(-0.66%)
-6.58EPS
3.06MMarket Cap

Total Valuation

USD

As of June 30, 2026, Catheter Precision, Inc. carries a market capitalization of 3.06M, placing it among publicly traded companies globally. Its enterprise value stands at 14.46M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap3.06M
Enterprise Value14.46M

Important Dates

Catheter Precision, Inc.'s next confirmed earnings release is scheduled for November 12, 2026.

Earnings Date11/12/2026

Share Statistics

As of June 30, 2026, Catheter Precision, Inc. has 3.61M shares outstanding.

Shares Outstanding3.61M

Valuation Ratios

These figures are as of June 30, 2026. The price-to-sales ratio is 0.89, and the price-to-book ratio stands at 0.17.

PS Ratio0.89
PB Ratio0.17
P/TBV Ratio-0.22
P/FCF Ratio-0.18
P/OCF Ratio-0.18

Enterprise Valuation

These figures are as of June 30, 2026. The EV/Sales ratio of 7.55 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 14.46M versus a market cap of 3.06M, with the gap driven by net debt and cash on the balance sheet.

EV / Sales7.55

Financial Position

As of June 30, 2026, Catheter Precision, Inc. maintains a current ratio of 0.19, meaning it holds 0.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 79.68, indicating elevated leverage, while an interest coverage ratio of -34.76 demonstrates limited ability to service its debt obligations.

Current Ratio0.19
Quick Ratio0.15
Debt / Equity79.68
Debt / EBITDA-0.81
Interest Coverage-34.76

Financial Efficiency

USD

Over the twelve months ended June 30, 2026, Catheter Precision, Inc. posted a negative return on equity (ROE) of -103.95, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -40.54, reflecting losses generated across the asset base. The company generates approximately 104,931.51 in revenue per employee across its workforce of 18.25, a quick read on workforce productivity versus industry peers. Inventory turnover of 14.72 indicates how many times Catheter Precision, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)-103.95
Return on Assets (ROA)-40.54
Revenue Per Employee104,931.51
Employee Count18.25
Inventory Turnover14.72

Taxes

USD

Over the twelve months ended June 30, 2026, Catheter Precision, Inc. recorded an income tax benefit of -623,000.00 rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -13.81M and -12.66M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Income Tax-623,000.00

Stock Price Statistics

USD

As of the close on October 2, 2026, Catheter Precision, Inc.'s stock has declined approximately 94.19% over the past 52 weeks. The 50-day moving average sits at 0.21, while the 200-day moving average is 1.02.

52-Week Price Change-94.19%
50-Day Moving Average0.21
200-Day Moving Average1.02

Income Statement

USD

Over the twelve months ended June 30, 2026, Catheter Precision, Inc. generated 1.92M in revenue and converted that into -12.66M in net income, yielding earnings per share of -6.58. EBITDA reached -16.96M, while operating income came in at -12.16M.

Revenue1.92M
Gross Profit914,000.00
Operating Income-12.16M
Pretax Income-13.81M
Net Income-12.66M
EBITDA-16.96M
EBIT-19.15M
Earnings Per Share (EPS)-6.58

Balance Sheet

USD

As of June 30, 2026, Catheter Precision, Inc. holds 1.84M in cash and equivalents against 13.66M in total debt, resulting in a net debt position of 10.38M. Total book value stands at 17.56M, with working capital of -10.94M providing operational flexibility.

Cash & Cash Equivalents1.84M
Total Debt13.66M
Net Debt10.38M
Equity (Book Value)17.56M
Book Value Per Share4.87
Working Capital-10.94M

Cash Flow

USD

Catheter Precision, Inc. produced -9.35M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -234,000.00 in capital expenditures, free cash flow totaled -9.59M - equivalent to -4.78 per share.

Operating Cash Flow-9.35M
Capital Expenditures-234,000.00
Free Cash Flow-9.59M
FCF Per Share-4.78

Margins

Over the twelve months ended June 30, 2026, Catheter Precision, Inc. posted a gross margin of 47.73, reflecting its pricing power and cost economics. The operating margin of -634.99 and net profit margin of -660.89 provide insight into operational efficiency.

Gross Margin47.73
Operating Margin-634.99
Pretax Margin-721.20
Profit Margin-660.89
EBITDA Margin-885.74

Dividends & Yields

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -563.22: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -362.84, meaning Catheter Precision, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Shareholder Yield-362.84
FCF Yield-563.22

Stock Splits

Catheter Precision, Inc.'s most recent stock split took place on August 15, 2025 with a 19:1 split ratio.

Last Split Date8/15/2025
Split Ratio19:1

Scores

As of June 30, 2026, Catheter Precision, Inc. has an Altman Z-Score of -92.55, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-92.55